Infectious Diseases

Insights

Infectious disease: another reason to try Veganuary for the NHS

30 January 2025

We dust off last year’s model to consider the potential savings to the NHS from more people going vegan, with a focus on COVID-19.

FINAL_OHE HVMF White Paper 2021_for posting 2-01
Publication

Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making

1 September 2021

By placing a strain on health care systems and the global economy, the COVID-19 pandemic clearly shows the need to more comprehensively understand both supply- and…

Key Factors on How to Procure, Pay and use Vaccines for COVID-19 2-01
Publication

Key Factors on How to Procure, Pay, Distribute and Use Vaccines for COVID-19: A European Perspective

1 May 2021

After the shock caused by the first wave of COVID-19, discovering vaccines against the virus and administering them quickly to the population became the utmost priority…

Publication

Realising The Broader Value of Vaccines in the UK: Ready for Prime Time?

1 February 2021

The COVID-19 pandemic has revealed the broad and devastating health, economic and societal impact of a highly infectious and deadly disease. In addition to the human…

How Should the World Pay for a COVID-19 Vaccine?
Publication

How Should the World Pay for a COVID-19 Vaccine?

1 July 2020

This year’s OHE lecture addresses the question: how should the world pay for a COVID-19 vaccine? Adrian Towse, Emeritus Director of OHE and Senior Research Fellow…

Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing?
Publication

Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing?

3 January 2020

Meningococcal disease is a life-threatening infection and can result in severe sequelae. Recent scientific and technical advances have led to the discovery and implementation of novel…

Publication

HTA and Payment Mechanisms for New Drugs to Tackle AMR

1 September 2019

Antimicrobial resistance (AMR) is a growing public health threat, limiting the ability of health care systems to prevent and treat infections and save lives. In parallel,…

R&D, Competition and Diffusion of Innovation in the EU cover page
Publication

R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C

1 July 2018

Using a multidisciplinary methodological approach combining a theoretical economic framework with uptake/market share analyses by country and interviews, this OHE research concludes that: (i) IP incentives…

Capture
Publication

Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?

1 October 2017

This briefing provides a detailed summary of a symposium held at the HTAi 2017 meeting in Rome. This briefing provides a detailed summary of a symposium…